Neuroone Medical Technologies (NMTC) Other Non Operating Income (2012 - 2026)
Neuroone Medical Technologies (NMTC) posted Other Non Operating Income of $23446.0 for Q1 2026, down 49.77% on a QoQ basis from $46677.0 in Q4 2025, and up 23.02% year-over-year from $19058.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Other Non Operating Income (2012 - 2026) Analysis & Trends
Neuroone Medical Technologies' Other Non Operating Income history runs 11 years deep, the most recent figure standing at $23446.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 23.02% year-over-year to $23446.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $212149.0 (up 175.3% YoY) and the FY2025 annual result came in at $170492.0, up 36.2% from the prior year.
- Other Non Operating Income was $23446.0 for Q1 2026 at Neuroone Medical Technologies, down from $46677.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $75432.0 in Q2 2025 and bottomed at -$26909.0 in Q1 2023.
- A 5-year average of $32968.1 and a median of $30315.5 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income sank 79.36% — and 2025, when it surged 396.14%.
- Neuroone Medical Technologies' Other Non Operating Income stood at $51583.0 in 2022, then fell by 11.65% to $45575.0 in 2023, then sank by 79.36% to $9408.0 in 2024, then jumped by 396.14% to $46677.0 in 2025, then plunged by 49.77% to $23446.0 in 2026.
- Business Quant data shows NMTC's Other Non Operating Income at $23446.0 in Q1 2026, $46677.0 in Q4 2025, and $66594.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,446.00 |
| Dec 31, 2025 | 46,677.00 |
| Sep 30, 2025 | 66,594.00 |
| Jun 30, 2025 | 75,432.00 |
| Mar 31, 2025 | 19,058.00 |
| Dec 31, 2024 | 9,408.00 |
| Sep 30, 2024 | 22,220.00 |
| Jun 30, 2024 | 26,376.00 |
| Mar 31, 2024 | 31,008.00 |
| Dec 31, 2023 | 45,575.00 |
| Sep 30, 2023 | 29,623.00 |
| Jun 30, 2023 | 41,462.00 |
| Mar 31, 2023 | -26,909.00 |
| Dec 31, 2022 | 51,583.00 |
| Jun 30, 2020 | -2.02 Mn |
| Mar 31, 2019 | -553,447.00 |
| Jun 30, 2018 | -537,134.00 |
| Mar 31, 2018 | -537,134.00 |
| Dec 31, 2017 | -350,914.00 |
| Sep 30, 2013 | -401.00 |